我們已在上線! 進一步了解
BTMDW圖示

Biote Corp. Warrant

已下市

BTMDW已於2023年7月6日下市。

 

關於: Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. The company offers end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support.

員工: 186

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於BTMDW的最新新聞文章。

價格圖表採用Lightweight Charts™實作